{"id":"umbilical-cord-blood","safety":{"commonSideEffects":[{"rate":null,"effect":"Graft-versus-host disease"},{"rate":null,"effect":"Infection"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"groq-llama-8b","explanation":"The exact mechanism of action is not fully understood, but it is believed that the stem cells in umbilical cord blood may help to repair damaged tissues and promote healing. This may be particularly useful in the treatment of certain medical conditions.","oneSentence":"Umbilical cord blood contains stem cells that may aid in tissue repair and regeneration.","_ai_confidence":"low"},"_scrapedAt":"2026-03-28T00:52:26.596Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Treatment of various conditions, including blood disorders, autoimmune diseases, and certain types of cancer"}]},"trialDetails":[{"nctId":"NCT01648855","phase":"","title":"Consequences of Antiangiogenic Factors Involved in Preeclampsia on Intra-uterine Growth Restricted Preterm Newborn","status":"COMPLETED","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2012-06","conditions":"Preterm Birth, Intra-uterine Growth Restriction, Maternal Preeclampsia","enrollment":33},{"nctId":"NCT06880003","phase":"NA","title":"Cord Blood Preptin Levels in Infants","status":"COMPLETED","sponsor":"Konya City Hospital","startDate":"2025-03-10","conditions":"Newborn Morbidity, Newborn Complication","enrollment":72},{"nctId":"NCT04628026","phase":"PHASE3","title":"Phase III Study of Induction and Consolidation Chemotherapy With Venetoclax in Patients With Newly Diagnosed AML or MDS-EB-2","status":"RECRUITING","sponsor":"University of Ulm","startDate":"2022-09-13","conditions":"Acute Myeloid Leukemia","enrollment":650},{"nctId":"NCT07444632","phase":"PHASE1","title":"Phase1 Basket Trial Of CAR.70-Engineered IL15-Transduced With TGFBR2 Knock Out Cord Blood-Derived NK Cells For Relapsed/Refractory Lymphoid Malignancies","status":"NOT_YET_RECRUITING","sponsor":"M.D. Anderson Cancer Center","startDate":"2026-08-31","conditions":"Lymphoid, Hodgkin Lymphoma","enrollment":60},{"nctId":"NCT03173937","phase":"PHASE1, PHASE2","title":"Unrelated Umbilical Cord Blood Transplantation for Severe Aplastic Anemia and Hypo-plastic MDS Using CordIn(TM), Umbilical Cord Blood-Derived Ex Vivo Expanded Stem and Progenitor Cells to Expedite Engraftment and Improve Transplant Outcome","status":"RECRUITING","sponsor":"National Heart, Lung, and Blood Institute (NHLBI)","startDate":"2017-06-13","conditions":"Severe Aplastic Anemia, Hypo-Plastic MDS, Myelodysplastic Syndrome (MDS)","enrollment":37},{"nctId":"NCT07492628","phase":"PHASE1","title":"Dual-Target Nectin-4/HER2 CAR-NK Cells in Advanced Urothelial Carcinoma","status":"RECRUITING","sponsor":"Beijing Biotech","startDate":"2026-03-02","conditions":"Bladder Cancer, Urothelial Carcinoma, Metastatic Urothelial Carcinoma","enrollment":42},{"nctId":"NCT04990323","phase":"PHASE1, PHASE2","title":"US Study of ECT-001-CB in Pediatric and Young Adult Patients With High-Risk Myeloid Malignancies","status":"COMPLETED","sponsor":"ExCellThera inc.","startDate":"2021-12-01","conditions":"High Risk Myeloid Malignancies, Cord Blood Transplant","enrollment":13},{"nctId":"NCT01861106","phase":"PHASE2","title":"Allogeneic Hematopoietic Stem Cell Transplant for GATA2 Mutations","status":"RECRUITING","sponsor":"National Cancer Institute (NCI)","startDate":"2013-07-24","conditions":"GATA2, Immunodeficiency, MDS","enrollment":144},{"nctId":"NCT07332338","phase":"","title":"Expanded Access Use of Human Umbilical Cord Blood (REGENECYTE) Infusion in Patients With Chronic Fatigue of Post-COVID Condition","status":"AVAILABLE","sponsor":"StemCyte, Inc.","startDate":"","conditions":"Post-COVID-19 Condition, Post-COVID Condition, Post-COVID Syndrome","enrollment":""},{"nctId":"NCT04103879","phase":"PHASE2","title":"US Study of UM171-Expanded CB in Patients With High Risk Leukemia/Myelodysplasia","status":"COMPLETED","sponsor":"ExCellThera inc.","startDate":"2020-11-13","conditions":"High Risk Hematological Malignancy, Cord Blood Transplant","enrollment":30},{"nctId":"NCT07339111","phase":"PHASE3","title":"Phase 3 Pivotal Trial Comparing CARTISTEM® and Surgical Comparator for Knee Cartilage Lesions and Osteoarthritis","status":"RECRUITING","sponsor":"Medipost, Inc.","startDate":"2026-03-11","conditions":"Knee Cartilage Defects","enrollment":300},{"nctId":"NCT06690151","phase":"","title":"Characterization and Support of Neurodevelopmental Disorders Associated With Congenital Cardiac malfoRmations - Neonatal","status":"RECRUITING","sponsor":"Nantes University Hospital","startDate":"2025-02-28","conditions":"Heart Disease Congenital, Neurodevelopmental Disorder","enrollment":450},{"nctId":"NCT03420963","phase":"PHASE1","title":"Donor Natural Killer Cells, Cyclophosphamide, and Etoposide in Treating Children and Young Adults With Relapsed or Refractory Solid Tumors","status":"TERMINATED","sponsor":"M.D. Anderson Cancer Center","startDate":"2018-08-31","conditions":"Recurrent Cutaneous Melanoma, Recurrent Lip and Oral Cavity Carcinoma, Recurrent Malignant Endocrine Neoplasm","enrollment":12},{"nctId":"NCT07101432","phase":"PHASE1","title":"Phase I Study of Preconditioning Radiation Therapy With IL-15 Transduced TGFBR2 KO CAR.TROP2-engineered Cord Blood-derived NK Cells in Patients With Advanced Head and Neck Cancer (RADIANCE-NK)","status":"RECRUITING","sponsor":"M.D. Anderson Cancer Center","startDate":"2025-11-04","conditions":"Head and Neck Cancer","enrollment":33},{"nctId":"NCT03441958","phase":"PHASE1, PHASE2","title":"ECT-001 (UM171) Expanded Cord Blood Transplant to Treat High-risk Multiple Myeloma","status":"COMPLETED","sponsor":"Ciusss de L'Est de l'Île de Montréal","startDate":"2018-03-07","conditions":"Multiple Myeloma","enrollment":19},{"nctId":"NCT05092451","phase":"PHASE1, PHASE2","title":"Phase I/II Study of CAR.70- Engineered IL15-transduced Cord Blood-derived NK Cells in Conjunction With Lymphodepleting Chemotherapy for the Management of Relapse/Refractory Hematological Malignances","status":"RECRUITING","sponsor":"M.D. Anderson Cancer Center","startDate":"2022-11-01","conditions":"B-Cell Lymphoma, Myelodysplastic Syndromes (MDS), Acute Myeloid Leukemia (AML)","enrollment":80},{"nctId":"NCT03835312","phase":"NA","title":"Sequential Transplantation of UCBSCs and Islet Cells in Children and Adolescents With Monogenic Immunodeficiency T1DM","status":"RECRUITING","sponsor":"Children's Hospital of Fudan University","startDate":"2019-02-20","conditions":"Diabetes Mellitus, Type 1, Immunologic Deficiency Syndromes","enrollment":50},{"nctId":"NCT07164560","phase":"PHASE1","title":"Exploratory Study of Umbilical Cord Blood-Derived CAR-NK Cell Therapy Targeting TRBC1/2 for Relapsed/Refractory T-Cell Lymphoma","status":"RECRUITING","sponsor":"Second Affiliated Hospital, School of Medicine, Zhejiang University","startDate":"2026-04-01","conditions":"Refractory/Recurrent Peripheral T-cell Lymphoma","enrollment":45},{"nctId":"NCT04347616","phase":"PHASE1, PHASE2","title":"Natural Killer-cell Therapy for Acute Myeloid Leukemia","status":"TERMINATED","sponsor":"Radboud University Medical Center","startDate":"2020-12-03","conditions":"Acute Myeloid Leukemia Refractory, Acute Myeloid Leukemia, Relapsed, Adult","enrollment":9},{"nctId":"NCT04644016","phase":"PHASE2","title":"Cord Blood Transplant in Children and Young Adults With Blood Cancers and Non-malignant Disorders","status":"RECRUITING","sponsor":"Memorial Sloan Kettering Cancer Center","startDate":"2020-11-20","conditions":"AML, ALL, MDS","enrollment":31},{"nctId":"NCT07467863","phase":"PHASE1, PHASE2","title":"Dual-Target CAR-NK Cells Directed Against MSLN, EGFR, or HER2 in Advanced NSCLC","status":"RECRUITING","sponsor":"Beijing Biotech","startDate":"2026-02-02","conditions":"Non-Small Cell Lung Cancer, Advanced/Metastatic NSCLC","enrollment":48},{"nctId":"NCT01962636","phase":"NA","title":"Umbilical Cord Blood Transplantation Using a Myeloablative Preparative Regimen for Hematological Diseases","status":"RECRUITING","sponsor":"Masonic Cancer Center, University of Minnesota","startDate":"2016-12","conditions":"Acute Myeloid Leukemia (AML), Acute Lymphocytic Leukemia (ALL), Chronic Myelogenous Leukemia","enrollment":200},{"nctId":"NCT07468201","phase":"","title":"Development of an Innovative Method to Extract Cord Blood Stem Cells With High Efficiency","status":"RECRUITING","sponsor":"Fondazione IRCCS Policlinico San Matteo di Pavia","startDate":"2024-04-10","conditions":"HSCs Extraction","enrollment":12},{"nctId":"NCT06930651","phase":"PHASE1, PHASE2","title":"A Phase I/II Study of CAR.70-Engineered IL15-Transduced Cord Blood-Derived NK Cells With TGF-beta Receptor 2 (TGFBR2) Knock Out in Conjunction With Lymphodepleting Chemotherapy for the Management of Relapsed/Refractory Myeloid Malignancies","status":"RECRUITING","sponsor":"M.D. Anderson Cancer Center","startDate":"2025-09-03","conditions":"Myeloid Malignancies","enrollment":42},{"nctId":"NCT07134712","phase":"PHASE2","title":"Safety and Efficacy of MiSaver (CB Cells) for Acute Myocardial Infarction, Phase II","status":"NOT_YET_RECRUITING","sponsor":"HONYA Medical Co Ltd","startDate":"2026-03-30","conditions":"Acute Myocardial Infarction (AMI)","enrollment":102},{"nctId":"NCT06066359","phase":"PHASE1, PHASE2","title":"Phase I/II Trial of Cord Blood-Derived NK Cells Genetically Engineered With NY-ESO-1 TCR/IL-15 Cell Receptor for Relapsed/Refractory Multiple Myeloma","status":"RECRUITING","sponsor":"M.D. Anderson Cancer Center","startDate":"2023-11-30","conditions":"Myeloma","enrollment":44},{"nctId":"NCT06345495","phase":"PHASE2","title":"High Dose Ruxolitinib and Allogeneic Stem Cell Transplantation in Myelofibrosis Patients With Splenomegaly","status":"RECRUITING","sponsor":"M.D. Anderson Cancer Center","startDate":"2024-10-01","conditions":"Splenomegaly, Myelofibrosis","enrollment":30},{"nctId":"NCT07372885","phase":"PHASE1, PHASE2","title":"GRanulocyte Augmented Cord Blood Transplantation for Poor Risk leukaEmia","status":"NOT_YET_RECRUITING","sponsor":"University of Manchester","startDate":"2026-02-09","conditions":"Acute Myeloid Leukemia, Stem Cell Transplantation, Stem Cell Transplantation, Hematopoietic","enrollment":50},{"nctId":"NCT04565665","phase":"PHASE1, PHASE2","title":"Study of Cord Blood Derived Mesenchymal Stem Cells for Treatment of Moderate, Severe or Critical Pneumonia","status":"RECRUITING","sponsor":"M.D. Anderson Cancer Center","startDate":"2020-07-29","conditions":"COVID-19 Infection, COVID-19-Associated Acute Respiratory Distress Syndrome, Hematopoietic and Lymphoid Cell Neoplasm","enrollment":70},{"nctId":"NCT07462650","phase":"PHASE1, PHASE2","title":"Dual-Target CAR-NK Cells for Biomarker-Selected Advanced Colorectal Cancer","status":"RECRUITING","sponsor":"Beijing Biotech","startDate":"2026-02-01","conditions":"Colorectal Cancer Metastatic, Adenocarcinoma of Colon","enrollment":48},{"nctId":"NCT07454122","phase":"PHASE1","title":"CD5CAR-NK Cells for Refractory Invasive Mold Disease","status":"NOT_YET_RECRUITING","sponsor":"Fundacion Clinic per a la Recerca Biomédica","startDate":"2026-05","conditions":"Fungal Infection","enrollment":10},{"nctId":"NCT03541889","phase":"PHASE1","title":"REVEAL Biomarkers of Engraftment After Alternative Donor HSCT","status":"RECRUITING","sponsor":"University of Oklahoma","startDate":"2021-02-05","conditions":"Primary Graft Failure","enrollment":56},{"nctId":"NCT05703854","phase":"PHASE1, PHASE2","title":"Study of CAR.70-engineered IL15-transduced Cord Blood-derived NK Cells in Conjunction With Lymphodepleting Chemotherapy for the Management of Advanced Renal Cell Carcinoma, Mesothelioma and Osteosarcoma","status":"RECRUITING","sponsor":"M.D. Anderson Cancer Center","startDate":"2023-03-29","conditions":"Advanced Renal Cell Carcinoma, Advanced Mesothelioma, Advanced Osteosarcoma","enrollment":50},{"nctId":"NCT07137481","phase":"PHASE2","title":"Phase II Study of CD5 CAR Engineered IL15-transduced Cord Blood-derived NK Cells in Conjunction With Lymphodepleting Chemotherapy for the Management of Aggressive T Cell Hematological Malignancies","status":"NOT_YET_RECRUITING","sponsor":"M.D. Anderson Cancer Center","startDate":"2027-02-28","conditions":"Hematological Malignancies","enrollment":70},{"nctId":"NCT06947473","phase":"PHASE1, PHASE2","title":"Umbilical Cord Blood CD19-BCMA CART Cell Therapy for SLE-LN, SSc, andpSS PAH.","status":"RECRUITING","sponsor":"Beijing GoBroad Hospital","startDate":"2026-03-18","conditions":"Refractory Lupus Nephritis, Systemic Sclerosis, Primary Sjogren's Syndrome Combined With Pulmonary Hypertension","enrollment":45},{"nctId":"NCT04477928","phase":"","title":"General Population Level Estimation for Type 1 Diabetes Risk in Children During Routine Care Delivery","status":"RECRUITING","sponsor":"Sanford Health","startDate":"2020-07-17","conditions":"Type 1 Diabetes, Celiac Disease","enrollment":33000},{"nctId":"NCT07441967","phase":"PHASE2","title":"The Safety and Efficacy of the Regimen of Thiotepa + Fludarabine +Granulocyte Colony-Stimulating Factor+ Cytarabine + Busulfan in Single Unrelated Umbilical Cord Blood Transplantation","status":"NOT_YET_RECRUITING","sponsor":"Institute of Hematology & Blood Diseases Hospital, China","startDate":"2026-02-20","conditions":"Hematologic Malignancies","enrollment":44},{"nctId":"NCT07441720","phase":"PHASE2","title":"Safety and Efficacy of Umbilical Cord Blood Therapy for Cancer Therapy-Induced Thrombocytopenia (CTIT)","status":"RECRUITING","sponsor":"Zhejiang Cancer Hospital","startDate":"2026-02-28","conditions":"Thrombocytopenia, Cancer Treatment-induced Thrombocytopenia","enrollment":25},{"nctId":"NCT07321041","phase":"","title":"Effect of Delivery Time on Umbilical Cord Blood Gas Parameters in Cesarean Sections Under General and Spinal Anesthesia","status":"RECRUITING","sponsor":"Sisli Hamidiye Etfal Training and Research Hospital","startDate":"2026-01-15","conditions":"Umbilical Cord Blood, Cesarean Section Surgery, General Anesthesia","enrollment":100},{"nctId":"NCT06904482","phase":"PHASE2","title":"Co-Transplant of an Unmodified Haplo-Identical Graft With Cord Blood","status":"RECRUITING","sponsor":"Case Comprehensive Cancer Center","startDate":"2025-08-13","conditions":"aGVHD, Acute Myelogenous Leukemia, Acute Lymphocytic Leukemia","enrollment":36},{"nctId":"NCT02730299","phase":"PHASE3","title":"Stem Cell Transplantation With NiCord® (Omidubicel) vs Standard UCB in Patients With Leukemia, Lymphoma, and MDS","status":"COMPLETED","sponsor":"Gamida Cell ltd","startDate":"2016-12-16","conditions":"Hematological Malignancies, Acute Lymphoblastic Leukemia (ALL), Acute Myelogenous Leukemia (AML)","enrollment":125},{"nctId":"NCT03158896","phase":"PHASE1","title":"Evaluation of Umbilical Cord-Derived Wharton's Jelly Stem Cells for the Treatment of Acute Graft Versus Host Disease","status":"COMPLETED","sponsor":"University of Kansas Medical Center","startDate":"2018-07-09","conditions":"Acute Graft Versus Host Disease","enrollment":24},{"nctId":"NCT07273643","phase":"","title":"Characterization of Extracellular Vesicles From the Cord Blood of Extremely Preterm New Borns and Their Correlation With Severe Morbidity and Mortality","status":"RECRUITING","sponsor":"University Hospital, Montpellier","startDate":"2026-01-13","conditions":"Intraventricular Hemorrhage, Pulmonary Hemorrhage, Death","enrollment":30},{"nctId":"NCT01366092","phase":"PHASE2","title":"Daily IL-2 for Steroid-Refractory Chronic Graft-versus-Host-Disease","status":"ACTIVE_NOT_RECRUITING","sponsor":"Dana-Farber Cancer Institute","startDate":"2011-07","conditions":"Chronic Graft-versus-host Disease","enrollment":35},{"nctId":"NCT06207799","phase":"PHASE2","title":"Pre-transplant Purging and Post-transplant MRD-guided Maintenance Therapy With Elranatamab in Patients With High-risk Multiple Myeloma","status":"RECRUITING","sponsor":"M.D. Anderson Cancer Center","startDate":"2024-07-17","conditions":"Multiple Myeloma, Post-transplant MRD-guided Maintenance Therapy, Pre-transplant Purging","enrollment":40},{"nctId":"NCT05922930","phase":"PHASE1, PHASE2","title":"Study of TROP2 CAR Engineered IL15-transduced Cord Blood-derived NK Cells Delivered Intraperitoneally for the Management of Platinum Resistant Ovarian Cancer, Mesonephric-like Adenocarcinoma, and Pancreatic Cancer","status":"RECRUITING","sponsor":"M.D. Anderson Cancer Center","startDate":"2023-10-11","conditions":"Pancreatic Cancer, Ovarian Cancer, Adenocarcinoma","enrollment":51},{"nctId":"NCT07411729","phase":"","title":"Establishment of a Biobank for the Evaluation of Rapid Diagnostic Solutions","status":"RECRUITING","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2024-06-03","conditions":"Emerging Infectious Diseases, Communicable Diseases, Biological Warfare Agents","enrollment":800},{"nctId":"NCT07412977","phase":"","title":"\"Pregnancy and Viral Infections: Impact on Pregnant Women and Their Children. French Prospective Cohort\"","status":"NOT_YET_RECRUITING","sponsor":"ANRS, Emerging Infectious Diseases","startDate":"2026-02","conditions":"HIV Infection, HBV Infection, HDV Infection","enrollment":5160},{"nctId":"NCT02382601","phase":"","title":"Longitudinal Study of Intra-Uterine Growth Restriction","status":"RECRUITING","sponsor":"University of Colorado, Denver","startDate":"2015-04","conditions":"IUGR, Pregnancy","enrollment":200},{"nctId":"NCT07408973","phase":"","title":"Prospective Twin Pregnancy Cohort at Montpellier University Hospital","status":"NOT_YET_RECRUITING","sponsor":"University Hospital, Montpellier","startDate":"2026-04-01","conditions":"Pregnancy, Twin","enrollment":360},{"nctId":"NCT02391519","phase":"","title":"Effects of High Altitude on AMPK Activation","status":"RECRUITING","sponsor":"University of Colorado, Denver","startDate":"2016-01","conditions":"Pregnancy, IUGR, Preeclampsia","enrollment":84},{"nctId":"NCT07401160","phase":"NA","title":"Umbilical Cord Drainage to Prevent Postpartum Hemorrhage","status":"RECRUITING","sponsor":"Universidad Nacional Autonoma de Honduras","startDate":"2026-02-15","conditions":"Postpartum Hemorrhage","enrollment":400},{"nctId":"NCT03657394","phase":"NA","title":"Comparative Outcomes Related to Delivery-room Cord Milking In Low-resourced Kountries","status":"ACTIVE_NOT_RECRUITING","sponsor":"Nemours Children's Clinic","startDate":"2022-10-17","conditions":"Hypoxic-Ischemic Encephalopathy, Birth Asphyxia","enrollment":3442},{"nctId":"NCT07296107","phase":"","title":"In Vitro Fertilization (IVF) and Prenatal Effects Independent of Genetics","status":"RECRUITING","sponsor":"Columbia University","startDate":"2026-05","conditions":"Maternal Distress, Child Development","enrollment":360},{"nctId":"NCT07212335","phase":"EARLY_PHASE1","title":"Safety and Efficacy of Umbilical Cord Blood-Derived Mesenchymal Stem Cells in the Treatment of Long-Term Cytopenia After CAR-T Therapy","status":"RECRUITING","sponsor":"Institute of Hematology & Blood Diseases Hospital, China","startDate":"2025-10-01","conditions":"Immune Effector Cell Associated Hematotoxicity","enrollment":15},{"nctId":"NCT01351545","phase":"","title":"A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)","status":"RECRUITING","sponsor":"Center for International Blood and Marrow Transplant Research","startDate":"2011-10","conditions":"Hematologic Malignancies, Inherited Disorders of Metabolism, Inherited Abnormalities of Platelets","enrollment":99999},{"nctId":"NCT02400853","phase":"NA","title":"Research a New Predictive Marker of Intraventricular Hemorrhage in Very Preterm Infants","status":"COMPLETED","sponsor":"University Hospital, Rouen","startDate":"2015-07-10","conditions":"Intraventricular Hemorrhage","enrollment":175},{"nctId":"NCT04484441","phase":"","title":"Maternal-fetal Immune Responses to Fetal Surgery","status":"COMPLETED","sponsor":"Mayo Clinic","startDate":"2022-03-24","conditions":"Spina Bifida, Congenital Diaphragmatic Hernia, Lower Urinary Tract Obstructive Syndrome","enrollment":21},{"nctId":"NCT01174875","phase":"","title":"Growing Up in Singapore Towards Healthy Outcomes","status":"ACTIVE_NOT_RECRUITING","sponsor":"National University Hospital, Singapore","startDate":"2009-06","conditions":"Metabolic Diseases, Neurological and Mental Health Conditions, Genetic Predisposition","enrollment":1247},{"nctId":"NCT03371641","phase":"NA","title":"In Utero Alcoholic Exposure: PlGF, Biomarker of Fetal Brain Lesions","status":"RECRUITING","sponsor":"University Hospital, Rouen","startDate":"2017-01-27","conditions":"Fetal Alcohol Syndrome","enrollment":60},{"nctId":"NCT07295067","phase":"PHASE1","title":"Extracellular Vesicles for the Treatment of Syringomyelia","status":"RECRUITING","sponsor":"Xuanwu Hospital, Beijing","startDate":"2025-12-23","conditions":"Syringomyelia","enrollment":18},{"nctId":"NCT07304440","phase":"PHASE1, PHASE2","title":"Adia MED of Winter Park LLC Autism Spectrum Disorder Research Study","status":"RECRUITING","sponsor":"Adia Med of Winter Park LLC","startDate":"2026-01-12","conditions":"Autism Spectrum Disorder, Autism, ASD","enrollment":100},{"nctId":"NCT05775718","phase":"PHASE2","title":"Shingrix In Recipients of Allogeneic Transplants","status":"RECRUITING","sponsor":"University of Colorado, Denver","startDate":"2023-10-24","conditions":"Bone Marrow Transplant, Stem Cell Transplant","enrollment":55},{"nctId":"NCT06565455","phase":"NA","title":"Growing Healthy Children and Families in Rural Arkansas","status":"RECRUITING","sponsor":"University of Arkansas","startDate":"2026-02-02","conditions":"Pediatric Obesity, Health Behavior, Risky","enrollment":64},{"nctId":"NCT07385326","phase":"NA","title":"Umbilical Cord Clamping Methods and Stem Cell Counts in Preterm Infants","status":"COMPLETED","sponsor":"Era Tufan Benli","startDate":"2015-01","conditions":"Preterm Birth, Umbilical Cord Clamping","enrollment":49},{"nctId":"NCT05110742","phase":"PHASE1, PHASE2","title":"Phase I/II Study of CD5 CAR Engineered IL15-Transduced Cord Blood-Derived NK Cells in Conjunction With Lymphodepleting Chemotherapy for the Management of Relapsed/Refractory Hematological Malignances","status":"RECRUITING","sponsor":"M.D. Anderson Cancer Center","startDate":"2024-04-22","conditions":"Hematological Malignancy","enrollment":64},{"nctId":"NCT06712108","phase":"","title":"Double Unit Cord Blood Transplant in Hematologic Malignancies.","status":"RECRUITING","sponsor":"Seoul National University Hospital","startDate":"2023-12-21","conditions":"Adult Double Unit Cord Blood Transplant","enrollment":40},{"nctId":"NCT07381738","phase":"PHASE2","title":"Unrelated Cord Blood Transplantation for EBV-associated Lymphoproliferative Disorders","status":"RECRUITING","sponsor":"Fudan University","startDate":"2026-01-01","conditions":"Epstein-Barr Virus-associated Lymphoproliferative Diseases, Chronic Active Epstein-Barr Virus Infection, EBV Associated Lymphoma","enrollment":80},{"nctId":"NCT07377526","phase":"PHASE1, PHASE2","title":"Phase 1/2 Study TROP2 CAREngineered Cord Blood-Derived NK Cells + Belzutifan In Pancreatic Cancer","status":"NOT_YET_RECRUITING","sponsor":"M.D. Anderson Cancer Center","startDate":"2026-07-01","conditions":"Pancreatic Cancer","enrollment":37},{"nctId":"NCT01733186","phase":"PHASE1, PHASE2","title":"Evaluation of Safety and Exploratory Efficacy of CARTISTEM®, a Cell Therapy Product for Articular Cartilage Defects","status":"COMPLETED","sponsor":"Medipost, Inc.","startDate":"2013-01-07","conditions":"Degeneration Articular Cartilage Knee","enrollment":12},{"nctId":"NCT05612919","phase":"NA","title":"Red Blood Cells From Umbilical Cord for Transfusion of Preterm Infants","status":"COMPLETED","sponsor":"Hospital Clinic of Barcelona","startDate":"2023-09-13","conditions":"Infant, Extremely Premature, Erythrocyte Transfusion, Umbilical Cord Issue","enrollment":41},{"nctId":"NCT06464965","phase":"PHASE1","title":"Clinical Study of Cord Blood-Derived CAR-NK Cells in Gastric Cancer and Pancreatic Cancer","status":"COMPLETED","sponsor":"Zhejiang Provincial People's Hospital","startDate":"2024-07-03","conditions":"Gastric Cancer, Pancreas Adenocarcinoma","enrollment":10},{"nctId":"NCT04991870","phase":"PHASE1","title":"Phase I CB-NK-TGF-ßR2-/NR3C1- in rGBM","status":"RECRUITING","sponsor":"M.D. Anderson Cancer Center","startDate":"2023-04-28","conditions":"Recurrent Gliosarcoma, Recurrent Supratentorial Glioblastoma, Supratentorial Gliosarcoma","enrollment":25},{"nctId":"NCT03327467","phase":"","title":"Expanded Access Protocol: Umbilical Cord Blood Infusions for Children With Brain Injuries","status":"AVAILABLE","sponsor":"Joanne Kurtzberg, MD","startDate":"","conditions":"Cerebral Palsy, Hydrocephalus, Apraxia of Speech","enrollment":""},{"nctId":"NCT06013423","phase":"PHASE2","title":"Cord Blood Transplant, Cyclophosphamide, Fludarabine, and Total-Body Irradiation in Treating Patients With High-Risk Hematologic Diseases","status":"RECRUITING","sponsor":"Fred Hutchinson Cancer Center","startDate":"2024-07-23","conditions":"Acute Leukemia of Ambiguous Lineage, Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia","enrollment":54},{"nctId":"NCT05331872","phase":"PHASE1","title":"Umbilical Cord-derived Mesenchymal Stem Cell Infusion in the Management of Adult Liver Cirrhosis","status":"COMPLETED","sponsor":"Vinmec Research Institute of Stem Cell and Gene Technology","startDate":"2021-01-01","conditions":"Liver Cirrhosis","enrollment":20},{"nctId":"NCT06415461","phase":"PHASE1","title":"A Study Assessing the Safety of Cord Blood Product in Sacroiliac Joint Syndrome (SIJ)","status":"ACTIVE_NOT_RECRUITING","sponsor":"University of Florida","startDate":"2024-05-10","conditions":"Sacroiliac; Backache, Pain, Back","enrollment":9},{"nctId":"NCT06812507","phase":"NA","title":"Evaluation of Placental Transfusion Techniques in Prevention of Prematurity Related Complications and Effect on Their Hematological Profile","status":"RECRUITING","sponsor":"Alexandria University","startDate":"2025-03-10","conditions":"Premature, Placental Transfusion","enrollment":160},{"nctId":"NCT01652092","phase":"NA","title":"Allogeneic Hematopoietic Stem Cell Transplant for Patients With Primary Immune Deficiencies","status":"ACTIVE_NOT_RECRUITING","sponsor":"Masonic Cancer Center, University of Minnesota","startDate":"2012-09-04","conditions":"SCID, Omenn's Syndrome, Reticular Dysgenesis","enrollment":57},{"nctId":"NCT06358430","phase":"PHASE1","title":"Dose Escalation and Expansion Study of TROP2 CAR Engineered IL-15- Transduced Cord Blood-derived NK Cells in Combination With Cetuximab in Patient With Colorectal Cancer (CRC) With Minimal Residual Disease (MRD)","status":"RECRUITING","sponsor":"M.D. Anderson Cancer Center","startDate":"2024-12-02","conditions":"Colorectal Cancer, Minimal Residual Disease","enrollment":42},{"nctId":"NCT04528355","phase":"","title":"Data Collection Study of Patients With Non-Malignant Disorders Undergoing UCBT, BMT or PBSCT With RIC","status":"RECRUITING","sponsor":"Paul Szabolcs","startDate":"2020-08-20","conditions":"Primary Immunodeficiency (PID), Congenital Bone Marrow Failure Syndromes, Inherited Metabolic Disorders (IMD)","enrollment":50},{"nctId":"NCT00012545","phase":"","title":"Collection and Storage of Umbilical Cord Stem Cells for Treatment of Sickle Cell Disease","status":"COMPLETED","sponsor":"National Heart, Lung, and Blood Institute (NHLBI)","startDate":"2001-11-01","conditions":"Sickle Cell Disease, Sickle Cell Trait","enrollment":307},{"nctId":"NCT04943289","phase":"PHASE1","title":"Intrathecal Administration of DUOC-01 in Adults With Primary Progressive Multiple Sclerosis","status":"COMPLETED","sponsor":"Joanne Kurtzberg, MD","startDate":"2021-01-24","conditions":"Primary Progressive Multiple Sclerosis","enrollment":20},{"nctId":"NCT03904134","phase":"NA","title":"Clinical Transplant-Related Long-term Outcomes of Alternative Donor Allogeneic Transplantation (BMT CTN 1702)","status":"COMPLETED","sponsor":"Center for International Blood and Marrow Transplant Research","startDate":"2019-06-14","conditions":"Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Myelodysplastic Syndromes","enrollment":1753},{"nctId":"NCT07316465","phase":"NA","title":"Birth Cohort: Development of IgE Autoantibodies in Newborns With (High Risk of) Atopic Dermatitis","status":"RECRUITING","sponsor":"Universitair Ziekenhuis Brussel","startDate":"2023-10-01","conditions":"Atopic Dermatitis (AD), Autoantibody, Auto-Immunity","enrollment":500},{"nctId":"NCT07297576","phase":"NA","title":"Safety and Feasibility of Sulforaphane to Promote Early Haematopoietic Recovery After Cord Blood Transplantation","status":"RECRUITING","sponsor":"Institute of Hematology & Blood Diseases Hospital, China","startDate":"2025-10-22","conditions":"ALL (Acute B-Lymphoblastic Leukemia), AML (Acute Myelogenous Leukemia, MDS (Myelodysplastic Syndrome)","enrollment":36},{"nctId":"NCT06991114","phase":"PHASE2","title":"AlloNK®, an Allogeneic Non-genetically Modified, Cord Blood-derived NK Cell Therapy, in Combination With Rituximab, Studied in Relapsing Forms of B-cell Dependent Rheumatologic Diseases.","status":"RECRUITING","sponsor":"Artiva Biotherapeutics, Inc.","startDate":"2025-07-09","conditions":"Refractory Rheumatoid Arthritis (RA), Idiopathic Inflammatory Myopathies (IIMs), Systemic Sclerosis (SSc)","enrollment":90},{"nctId":"NCT07301866","phase":"PHASE1, PHASE2","title":"A Study Testing an Improved Dose of UM171 to Help Make Cord Blood Transplants More Effective and Safe.","status":"RECRUITING","sponsor":"Ciusss de L'Est de l'Île de Montréal","startDate":"2025-10-06","conditions":"Acute Leukemia, High Risk, Myelodysplastic Syndromes, High Risk, Hematologic Malignancy Requiring an Allogeneic Hematopoietic Stem Cell Transplant Lacking a Donor","enrollment":7},{"nctId":"NCT03828344","phase":"PHASE1","title":"Safety and Tolerability of a Single Intravenous Infusion of BX-U001 in Refractory Rheumatoid Arthritis","status":"NOT_YET_RECRUITING","sponsor":"Baylx Inc.","startDate":"2026-12-01","conditions":"Rheumatoid Arthritis","enrollment":16},{"nctId":"NCT07047456","phase":"PHASE3","title":"Effect of Stem Cell Infusion Time on aGVHD in Patients With Hematological Malignancies Post UCBT","status":"RECRUITING","sponsor":"Anhui Provincial Hospital","startDate":"2025-07-11","conditions":"Acute Graft Versus Host Disease","enrollment":134},{"nctId":"NCT00639964","phase":"NA","title":"Exploration of the Lipid Metabolism During the Diabetic Pregnancies","status":"COMPLETED","sponsor":"University Hospital, Lille","startDate":"2008-01","conditions":"Pregnancy, Pregnancy in Diabetes, Type 1 Diabetes Mellitus","enrollment":186},{"nctId":"NCT07296393","phase":"","title":"Vitamin A in Cord Blood and Preterm Outcomes","status":"NOT_YET_RECRUITING","sponsor":"The First Hospital of Jilin University","startDate":"2025-12-10","conditions":"Extremely Premature Infant","enrollment":155},{"nctId":"NCT01451502","phase":"NA","title":"Infusion of Cell Populations From Unlicensed Umbilical Cord Blood Units","status":"RECRUITING","sponsor":"Masonic Cancer Center, University of Minnesota","startDate":"2011-10-20","conditions":"Lymphatic Diseases, Hematopoietic Malignancy","enrollment":250},{"nctId":"NCT01962415","phase":"PHASE2","title":"Reduced Intensity Conditioning for Non-Malignant Disorders Undergoing UCBT, BMT or PBSCT","status":"RECRUITING","sponsor":"Paul Szabolcs","startDate":"2014-02-04","conditions":"Primary Immunodeficiency (PID), Congenital Bone Marrow Failure Syndromes, Inherited Metabolic Disorders (IMD)","enrollment":100},{"nctId":"NCT07279545","phase":"NA","title":"The Effect of Placental Cord Drainage on the Third Stage of Labor and the Amount of Postpartum Bleeding","status":"RECRUITING","sponsor":"Saglik Bilimleri Universitesi Gulhane Tip Fakultesi","startDate":"2025-11-17","conditions":"Postpartum Hemorrhage","enrollment":80},{"nctId":"NCT02184676","phase":"NA","title":"T1D Risk Assessment in Kids With Relatives","status":"COMPLETED","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2015-05-28","conditions":"Type 1 Diabetes","enrollment":512},{"nctId":"NCT07274059","phase":"EARLY_PHASE1","title":"Allogeneic UCB-derived CAR-T for SLE","status":"RECRUITING","sponsor":"Chengdu Ucello Biotechnology Co., Ltd.","startDate":"2025-03-26","conditions":"SLE - Systemic Lupus Erythematosus","enrollment":48},{"nctId":"NCT06265220","phase":"PHASE1","title":"AB-101 in Combination With B-Cell Depleting mAb in Patients Who Failed Treatment for Class III or IV Lupus Nephritis or Other Forms of Refractory Systemic Lupus Erythematosus","status":"ACTIVE_NOT_RECRUITING","sponsor":"Artiva Biotherapeutics, Inc.","startDate":"2024-04-03","conditions":"Lupus Nephritis - WHO Class III, Lupus Nephritis - WHO Class IV, Refractory Systemic Lupus Erythematosus","enrollment":51},{"nctId":"NCT02916732","phase":"","title":"Zika Virus Infection's Pregnancy Consequences in French Department of America","status":"COMPLETED","sponsor":"Institut National de la Santé Et de la Recherche Médicale, France","startDate":"2016-04","conditions":"Incidence of ZIKV Infection on Fetus During the Pregnancy","enrollment":26980},{"nctId":"NCT02251821","phase":"PHASE2","title":"JAK Inhibitor Before Donor Stem Cell Transplant in Treating Patients With Primary or Secondary Myelofibrosis","status":"ACTIVE_NOT_RECRUITING","sponsor":"Fred Hutchinson Cancer Center","startDate":"2014-10-20","conditions":"Primary Myelofibrosis, Secondary Myelofibrosis","enrollment":61}],"_emaApprovals":[],"_faersSignals":[{"count":2,"reaction":"STEM CELL TRANSPLANT"},{"count":2,"reaction":"TRANSPLANT FAILURE"},{"count":2,"reaction":"VOMITING"},{"count":1,"reaction":"ACUTE MYELOID LEUKAEMIA"},{"count":1,"reaction":"ACUTE RESPIRATORY FAILURE"},{"count":1,"reaction":"ASTHENIA"},{"count":1,"reaction":"BACTERAEMIA"},{"count":1,"reaction":"BLOOD CALCIUM INCREASED"},{"count":1,"reaction":"BLOOD IRON DECREASED"},{"count":1,"reaction":"BURNING SENSATION"}],"_approvalHistory":[],"publicationCount":12936,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["UCB","cord blood","hematopoietic stem cells"],"phase":"phase_3","status":"active","brandName":"Umbilical cord blood","genericName":"Umbilical cord blood","companyName":"Shandong Qilu Stem Cells Engineering Co., Ltd.","companyId":"shandong-qilu-stem-cells-engineering-co-ltd","modality":"Biologic","firstApprovalDate":"","aiSummary":"Umbilical cord blood contains stem cells that may aid in tissue repair and regeneration. Used for Treatment of various conditions, including blood disorders, autoimmune diseases, and certain types of cancer.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":1,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}